Weight Loss & Metabolic
GLP-1s, retatrutide, AOD-9604 and metabolic research discussion. 40 discussions in this community. Create a free account to ask a question or share your experience.
Discussions in Weight Loss & Metabolic
- Amlexanox 4 weeks in, tracking HRV, glucose, weight - 1 points, 0 comments
- Semaglutide titration and resting heart rate, anyone else tracking this? - 2 points, 0 comments
- FDA cracking down on compounded GLP-1s, what happens to access? - 2 points, 4 comments
- Retatrutide Phase 3 data is out and the numbers are proper wild - 6 points, 4 comments
- Compounded GLP-1 safety gaps are getting worse, not better - 0 points, 8 comments
- FDA trying to kill compounded GLP-1s again - 7 points, 4 comments
- CagriSema week 2 and I'm weirdly hungry, is this the loading phase being aggressive? - 4 points, 5 comments
- CagriSema vs plain sema, anyone actually compare the two? - 2 points, 4 comments
- CagriSema vs straight sema, has anyone actually compared the two? - 4 points, 4 comments
- WHO says GLP-1 supply bottleneck could derail obesity fight, wants price cuts - 3 points, 4 comments
- Novo's GLP-1 fall from grace, what the MarketWatch deep dive actually shows - 2 points, 4 comments
- CagriSema week 6, finally broke my stall, here are the numbers - 4 points, 4 comments
- CagriSema week 4, glucose numbers look weird, is this a thing? - 2 points, 6 comments
- Cochrane says GLP-1s work for weight loss, but we need more independent trials - 2 points, 4 comments
- Semaglutide titration and HRV crashing, anyone else tracking this? - 2 points, 3 comments
- Australian woman hospitalised after telehealth prescribed weight-loss drugs her GP refused - 2 points, 4 comments
- CagriSema vs retatrutide, which one actually feels less rough on the stomach? - 0 points, 6 comments
- Novo Nordisk lost the GLP-1 race and I'm not even surprised - 3 points, 6 comments
- Anyone pairing berberine with a GLP-1, and did it actually move fasting glucose for you? - 2 points, 6 comments
- Weight loss injections are making obesity a wealth problem - 2 points, 6 comments
- FDA warning 30 telehealth sites over compounded GLP-1 marketing - 3 points, 4 comments
- Anyone actually break a stall on CagriSema without bumping the dose? - 3 points, 3 comments
- White House deal on Wegovy and Zepbound pricing, what it actually changes - 2 points, 4 comments
- Compounded semaglutide was supposed to fade out when the shortage ended. It didnt. - 2 points, 6 comments
- Survodutide glucagon arm, anyone splitting out the energy expenditure vs pure appetite effects? - 3 points, 4 comments
- Lipotropic MIC + carnitine shots, anyone actually tracking these against scale data? - 1 points, 4 comments
- CagriSema data actually looking better than tirz, anyone watching this one - 2 points, 4 comments
- Retatrutide 71 lb average loss is wild, but those discontinuation numbers bother me - 3 points, 4 comments
- CagriSema dual pathway, anyone tracking both appetite and blood glucose separately? - 5 points, 3 comments
- Anyone tracking actual metabolic rate on GLP-1s, not just the scale? - 2 points, 7 comments
- Genetics might predict who actually responds to GLP-1s, and I'm kinda into this - 3 points, 4 comments
- Plateau week 6 on tirz, am I the only one who wants to eat the entire fridge - 2 points, 6 comments
- Two deaths in NI reported to the watchdog, over 500 adverse reaction reports total - 3 points, 6 comments
- MHRA greenlights orforglipron, UK gets oral GLP-1 before the rest of Europe - 2 points, 4 comments
- Generic semaglutide could cost $3 a month, so why are we still paying $1000? - 2 points, 4 comments
- $3 a month generic semaglutide could change the math for millions - 7 points, 6 comments
- GLP-1 compounders still flying under the radar even after the pricing deal - 2 points, 6 comments
- CagriSema dual pathway appetite suppression, anyone tried it off-label yet? - 1 points, 6 comments
- CagriSema dual pathway appetite suppression, anyone tried it off-label yet? - 2 points, 3 comments
- Nature paper finds genetic variants that predict GLP-1 weight loss response - 4 points, 4 comments
Related compounds
- AOD-9604 - Advanced Obesity Drug Fragment 176-191 (Modified)
- Semaglutide - Semaglutide (GLP-1 Receptor Agonist)
- Tirzepatide - Tirzepatide (Dual GIP/GLP-1 Receptor Agonist)
- Retatrutide - Retatrutide (Triple Agonist GIP/GLP-1/Glucagon)
- Tesofensine - Tesofensine (Triple Monoamine Reuptake Inhibitor)
- CagriSema - CagriSema (Cagrilintide + Semaglutide)
- Survodutide - Survodutide (Dual GLP-1/Glucagon Agonist)
- Orforglipron - Orforglipron (Oral Non-Peptide GLP-1 Agonist)
Community discussion - research and educational context only. Not medical advice.